| On March 15, 2023, the Centers for Medicare and Medicaid Services released its much-anticipated initial guidance about how it intends to implement the drug negotiation provisions of the Inflation Reduction Act. ZS experts took a first look at implications for drugmakers. Here’s what they found. |
